N/A
N=43
14-Day Cumulative Irritation Patch Test in Subjects With Normal Skin
Cumulative Irritation
Bottom Line
View on ClinicalTrials.gov: NCT02309294 ↗Enrolled (actual)
43
Serious AEs
0.0%
Results posted
Oct 2016
Primary outcome: Primary: Number of Subjects That Showed no Significant Irritation — 0 participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Novel lubricant Miami w/ fragrance (Device); Novel lubricant Miami no fragrance (Device); KY Liquid lubricant (Device); Astroglide Gel lubricant (Device); Wet Platinum lubricant (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Church & Dwight Company, Inc.
- Primary completion
- Dec 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Subjects That Showed no Significant Irritation |
— | — |
Summary
The objective of this study is to determine the ability of the study material to cause irritation to the skin of humans under controlled patch test conditions. Substances that come into contact with human skin need to be evaluated for their propensity to irritate and/or sensitize. This testing is a modified primary irritancy patch test that can detect weak irritants that require multiple applications to cause a skin reaction.
Eligibility Criteria
Inclusion Criteria
- Are a male or female, 18 years of age or older, in general good health;
- Have normal skin;
- Are free of any systemic or dermatologic disorder which, in the opinion of the investigative personnel, will interfere with the study results or increase the risk of adverse events;
- Are of any skin type or race providing the skin pigmentation will allow discernment of erythema;
- Complete a medical screening procedure; and
- Read, understand, and sign an informed consent.
Exclusion Criteria
- Have any visible skin disease at the study site which, in the opinion of the investigative personnel, will interfere with the evaluation;
- Are receiving systematic or topical drugs or medication which, in the opinion of the investigative personnel, will interfere with the study results;
- Have psoriasis and/or active atopic dermatitis/eczema; and/or
- Have a known sensitivity to cosmetics, skin care products, or topical drugs as related to the material being evaluated.
Data sourced from ClinicalTrials.gov (NCT02309294). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.